tiprankstipranks
Trending News
More News >

Craig-Hallum bullish on Veracyte, initiates with a Buy

As previously reported, Craig-Hallum initiated coverage of Veracyte (VCYT) with a Buy rating and $45 price target The firm sees a lot of upside to estimates, which should drive the stock. Further, Craig-Hallum sees Veracyte as a “sleep at night” story, with market-leading products with room for growth, industry-leading margins, a strong balance sheet, positive cash flows, and a management team with a history of consistent beats and raises.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue